Nuvaxovid is a vaccine used for active immunisation for the prevention of COVID-19, a disease caused by the SARS-CoV-2 virus, in people aged 12 years or older. The vaccine causes the immune system (the body's natural defenses) to produce antibodies and specialised white blood cells to fight the virus, in order to provide protection against COVID-19. None of the components of this vaccine is capable of causing SARS-CoV-2 or COVID-19 infection.